의료진 소개
| 성명 | 최혜진 조교수 |
|---|---|
| 진료과 | 연세암센터-종양내과 |
| 전문진료분야 | 간암∙담도암∙췌장암,뇌종양 (금오후:완화의료클리닉) |
진료 시간표
| 진료시간 | 월 | 화 | 수 | 목 | 금 | 토 | ||
|---|---|---|---|---|---|---|---|---|
| 오전 | 암병원 | 암병원 | 암병원 | |||||
| 오후 | 암병원 | 암병원 | 암병원 | 암병원 | ||||
간암, 담도암, 췌장암, 신약임상치료
기본정보
논문저서
| 교육 및 임상 경력 |
2001.3~2006.2 세브란스병원 인턴, 레지던트
2006.3~2008.2 세브란스병원 혈액종양내과 강사
2008.3~2009.2 종양내과 임상연구조교수
2009.3~ 종양내과 임상조교수
|
|---|---|
| 학력사항 |
1995.03~2001.02 연세대학교 학사
2004.03~2006.02 연세대학교 석사
2007.09~박사 과정
|
|
진행성 간암의 치료, 대한간암연구회지, 2011년 제11호 전이성 간암의 치료, 대한내과학회지, 2011년 제81권 3호 Congenital absence of inferior vena cava as a rare cause of pulmonary thromboembolism YONSEI MEDICAL JOURNAL 45:947~951,2004 항인지질 증후군 환자에서 동반된 간문맥 혈전증 1예 대한내과학회지(korean Journal of medcine) 68 1:99~104,2005 A pilot study of trans-arterial injection of 166Holmium-Chitosan complex for treatment of small hepatocellular carcinoma YONSEI MEDICAL JOURNAL 46 6:799~805,2005 Phase II trial of irinotecan and cisplatin with early concurrent radiotherapy in limited-disease small-cell lung cancer CANCER 109 9:1845~1850,2007 Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib JOURNAL OF CLINICAL ONCOLOGY 25 18:2528~2533,2007 Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: A 15-year experience at a single Institute JOURNAL OF SURGICAL ONCOLOGY 95:461~468,2007 VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth MOLECULAR THERAPY 15 2:295~302,2007 Cetuximab rescue a patient with non-small cell lung cancer from rapid disease progression during chemotherapy ACTA ONCOLOGICA 46 4:547~549,2007 Phase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancer Radiotherapy And Oncology 87:361~366,2008 Capecitabine and doxorubicin combination chemotherapy as salvage therapy in pretreated advanced gastric cancer Cancer Chemotherapy And Pharmacology 61:157~165,2008 The combination of capecitabine and irinotecan in treating 5-Fluorouracil- and Oxaliplatin-pretreated metastatic colorectal cancer Cancer Chemotherapy And Pharmacology 61:75~81,2008 A single institutional experience of surgically resected thymic epithelial tumors over 10 years - Clinical outcomes and clinicopathologic features Oncology Reports 19:1525~1531,2008 Combination of topotecan and etoposide as a salvage treatment for patients with recurrent small cell lung cancer following irinotecan and platinum first-line chemotherapy Cancer Chemotherapy And Pharmacology 61:309~313,2008 Standardization of the Korean version of Mini-Mental Adjustment to Cancer (K-Mini-MAC) scale: factor structure, reliability and validity Psycho-Oncology 17:592~597,2008 The number of residual metastatic lymph nodes following neoadjuvant chemotherapy predicts survival in patients with stage III NSCLC Lung Cancer 60 3:393~400,2008 Phase II Study of Transarterial Holmium-166-Chitosan Complex Treatment in Patients with a Single, Large Hepatocellular Carcinoma Oncology 76 1:1~9,2009 Activating mutations within the EGFR kinase domain: a molecular predictor of disease-free survival in resected pulmonary adenocarcinoma JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 135 12:1647~1654,2009 High tumor metabolic activity as measured by fluorodeoxyglucose positron emission tomography is associated with poor prognosis in limited and extensive stage small-cell lung cancer Clinical Cancer Research 15 7:2426~2432,2009 Double E1B 19 kDa- and E1B 55 kDa-deleted oncolytic adenovirus in combination with radiotherapy elicits an enhanced anti-tumor effect GENE THERAPY 16:1111~1121,2009 Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck CANCER CHEMOTHERAPY AND PHARMACOLOGY 65 1:27~32,2009 Brain metastases from hepatocellular carcinoma: prognostic factors and outcome Journal Of Neuro-Oncology 91 3:307~313,2009 Complete Response of Recurrent Squamous Cell Carcinoma of the Lung: Dose the Dose Matter? Journal Of Thoracic Oncology 4 1:141~142,2009 Weekly 5-fluorouracil plus cisplatin for concurrent chemoradiotherapy in patients with locally advanced head and neck cancer Head and Neck 32 2:235~243,2010 Frequent central nervous system failure after clinical benefit with epidermal growth factor receptor tyrosine kinase inhibitors in Korean patients with nonsmall-cell lung cancer Cancer 116 5:1336~1343,2010 Phase II study of preoperative chemoradiotherapy (CRT) with irinotecan plus S-1 in locally advanced rectal cancer Radiotherapy And Oncology 95 3:303~307,2010 Paclitaxel combined with ifosfamide in anthracycline- and docetaxel-pretreated metastatic breast cancer: activity independence of prior docetaxel resistance CANCER CHEMOTHERAPY AND PHARMACOLOGY 66 3:425~431,2010 Belotecan for relapsing small-cell lung cancer patients initially treated with an irinotecan-containing chemotherapy: A phase II trial Lung Cancer 70 1:77~81,2010 Outcome of Adjuvant Therapy for Gallbladder Cancer Oncology 79 3-4:168~173,2010 Prognostic Factors in Small Cell Lung Cancer: A New Prognostic Index in Korean Patients Oncology 79 3-4:293~300,2010 MEKK1/MEKK4 are responsible for TRAIL-induced JNK/p38 phosphorylation ONCOLOGY REPORTS 25 2:537~544,2011 A phase I study of nimotuzumab in combination with radiotherapy in stages IIB-IV non-small cell lung cancer unsuitable for radical therapy: Korean results LUNG CANCER 71 1:55~59,2011 Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 137 4:659~667,2011 Evaluation of Bone Metastasis from Hepatocellular Carcinoma Using 18F-FDG PET/CTand 99mTc-HDP Bone Scintigraphy: Characteristics of Soft Tissue Formation Nuclear Medicine and Molecular Imaging 45 3:203~211,2011 Serous Cystic Neoplasm: Do We Have to Wait Till It Causes Trouble? 한국간담췌외과학회지 15 2:134~138,2011 Prognostic value of 18F-FDG PET for hepatocellular carcinoma patients treated with sorafenib. LIVER INTERNATIONAL 31 8:1144~1149,2011 전이성 간암의 치료 Korean J Med 81 3:279~288,2011 진행성 간암에서 전신 요법 대한간암연구학회지 11 1:33~39,2011 Potential Contribution of Preoperative Neoadjuvant Concurrent Chemoradiation Therapy on Margin-Negative Resection in Borderline Resectable Pancreatic Cancer JOURNAL OF GASTROINTESTINAL SURGERY 16 3:509~517,2012 Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study LANCET ONCOLOGY 13 2:181~188,2012 In Vitro Adenosine Triphosphate-Based Chemotherapy Response Assay in Solid Pseudopapilary Tumor of the Pancreas PANCREAS 41 3:498~500,2012 Sorafenib versus cytotoxic chemotherapy for patients with advanced hepatocellular carcinoma: a retrospective, single-institution study INVESTIGATIONAL NEW DRUGS 30 3:1150~1157,2012 |